The Future of "Dual-Action" Therapeutics and Targeted Delivery in France The technology inside the inhaler is becoming as sophisticated as the molecules themselves this year. In 2026, the France Asthma COPD Drugs Market is entering the era of "Site-Specific" delivery. New "Soft Mist" inhalers and dry powder systems are being engineered to deposit medication deep into the "Small Airways" of the lungs, which are often the hardest areas to treat in severe COPD. This...
0 แชร์
580 ยอดวิว
0 รีวิว